WeedMD Completes $13.1 Million Bought Deal Financing

September 25, 2019

WeedMD Inc. (TSXV: WMD), a federally-licensed producer and distributor of medical grade cannabis, completed a $13.1M bought deal short form prospectus offering of convertible debenture units. The offering was conducted by a syndicate of underwriters led by Mackie Research Capital Corporation, and included Haywood Securities Inc.

Wildeboer Dellelce LLP acted for the underwriters in connection with the offering with a team comprised of Jeff Hergott, Danny Kharazmi, Phil Lamothe, Colin Romano (corporate/securities), and Katy Pitch (Tax).